An enzyme known to be critical for the repair of damaged cells and the maintenance of cellular energy may be a useful target for new strategies to treat Huntington's disease and other disorders characterized by low cellular energy levels. A research team from the MassGeneral Institute for Neurodegenerative Disease has discovered a novel inhibitor of Poly (ADP-ribose) polymerase (PARP1) and found

[News Source]